Eli Lilly Neurocept Disclosure

Has Eli Lilly publicly disclosed trial identifiers, press releases, or peer‑reviewed data for a drug named Neurocept reported to have Phase II Alzheimer’s results?

There is no evidence in the provided reporting that Eli Lilly has publicly disclosed trial identifiers, press releases, or peer‑reviewed data for any drug called "Neurocept"; the company has, however,...